CNO

#1313
CNO Financial Group, Inc. Common Stock
56.7 0 USD
+0.02%
Market Price
Settore: Finanziario
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
56.63
56.81
Intervallo Annuale
38.22
57.30
Variazione giornaliera
+2.49%
Variazione Mensile
+1.96%
Variazione di 6 mesi
+35.65%
Variazione Annuale
+40.56%
Chiusura Precedente
55.3 2
Open
56.6 4
Minimo
56.6 3
Massimo
56.8 1
Volume
282
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, 01 Sep 2026
CNO Financial Group, Inc. current report, 01 September 2026
8-K
Current report, Q3 FY2026
CNO Financial Group, Inc. current report, Q3 FY2026
8-K
Institutional holdings, Q2 FY2026
CNO Financial Group, Inc. institutional holdings, Q2 FY2026
13F-HR
Quarterly report, Q2 FY2026
CNO Financial Group, Inc. quarterly report, Q2 FY2026
10-Q
INFORMATION TABLE, Q2 FY2026
CNO Financial Group, Inc. INFORMATION TABLE, Q2 FY2026
INFORMATION TABLE
Current report, Q2 FY2026
CNO Financial Group, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
CNO Financial Group, Inc. current report, Q2 FY2026
8-K
Institutional holdings, Q1 FY2026
CNO Financial Group, Inc. institutional holdings, Q1 FY2026
13F-HR
Quarterly report, Q1 FY2026
CNO Financial Group, Inc. quarterly report, Q1 FY2026
10-Q
INFORMATION TABLE, Q1 FY2026
CNO Financial Group, Inc. INFORMATION TABLE, Q1 FY2026
INFORMATION TABLE

CNO Financial Group, Inc. current report, 02 February 2010

Full document

Business Context and Reporting Period

This Form 8-K is a current report filed by Conseco, Inc. (noting the metadata reference to CNO Financial Group, Inc.) on February 2, 2010. The filing addresses corporate governance changes, specifically the election of a new director and amendments to the company's bylaws.

Key Financial Metrics

This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. However, it references significant capital transactions completed in November 2009:

  • Equity Financing: Sale of 16.4 million shares of common stock and warrants for 5.0 million shares to Paulson & Co. Inc. for an aggregate purchase price of $77.9 million.
  • Debt Financing: Issuance of $176.5 million in aggregate principal amount of 7.0% Convertible Senior Debentures due 2016.
  • Secondary Debt Transactions: Paulson funds purchased $120.5 million of the debentures from Morgan Stanley, with agreements to purchase up to an additional $79.5 million.

Material Changes

The primary material changes reported in this filing are:

  • Board Composition: Charles Murphy, Senior Vice President of Paulson & Co. Inc., was elected as an additional director and appointed to the Investment Committee.
  • Bylaw Amendment: The Board amended the Company's Bylaws to increase the number of directors to 10 to accommodate the new election.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors. It serves strictly to disclose the appointment of a director and the corresponding bylaw amendment. The text references prior filings (October 13, 2009, and October 19, 2009) for details regarding the Stock and Warrant Purchase Agreement and the Convertible Senior Debentures.

Investor Verification Checklist

  • Verify the terms of the Investor Rights Agreement entered into with Paulson & Co. Inc. on November 13, 2009.
  • Review the October 13, 2009, and October 19, 2009, Form 8-K filings for full details on the $77.9 million equity sale and the $176.5 million debenture offering.
  • Confirm the status of the additional $79.5 million debenture purchase agreements between Paulson funds and Morgan Stanley.
  • Examine the Amended and Restated Bylaws (Exhibit 3.2) to understand the new director structure.